Stay updated on All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Sign up to get notified when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.

Latest updates to the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.SummaryDifference5%

- Check27 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check42 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed, indicating a minor UI change.SummaryDifference0.3%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check56 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with recent publications related to nintedanib and interstitial lung disease. Notably, previous references to idiopathic pulmonary fibrosis and various related medical terms have been removed.SummaryDifference11%

- Check70 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the All-Case Surveillance of Ofev in Patients With IPF in Japan Clinical Trial page.